Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Orthomyxoviridae Infections (immunology) - Orthomyxoviridae Infections (prevention & control)

Terms

50Orthomyxoviridae Infections (immunology)
40Orthomyxoviridae Infections (prevention & control)
31Orthomyxoviridae Infections (virology)
47Antibodies, Viral (blood)
26Neutralization Tests
54Hemagglutination Inhibition Tests
36Antibodies, Viral (analysis)
17Orthomyxoviridae Infections (pathology)

Associations

Freq.WeightAssociation
2020Orthomyxoviridae Infections (immunology) - Orthomyxoviridae Infections (prevention & control)
1616Orthomyxoviridae Infections (immunology) - Orthomyxoviridae Infections (virology)
1515Antibodies, Viral (blood) - Orthomyxoviridae Infections (prevention & control)
1212Antibodies, Viral (blood) - Neutralization Tests
1212Antibodies, Viral (blood) - Hemagglutination Inhibition Tests
1313Antibodies, Viral (analysis) - Hemagglutination Inhibition Tests
1111Orthomyxoviridae Infections (prevention & control) - Orthomyxoviridae Infections (virology)
1010Hemagglutination Inhibition Tests - Neutralization Tests
99Orthomyxoviridae Infections (immunology) - Orthomyxoviridae Infections (pathology)

Documents par ordre de pertinence
002E13 (????) M V Sergeeva ; V V Kuznetsov ; M A Kas'Ianenko ; A A Shaldzhian ; I A Repko ; M V Potapchuk ; Iu R. Romanova ; L M Tsybalova[Immunization with live attenuated A/H5N1 vaccine protects guinea pigs from reinfection].
000724 (2014) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Xing Cheng [États-Unis] ; Fernando Torres-Velez [États-Unis] ; Marlene Orandle [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Evaluation of Three Live Attenuated H2 Pandemic Influenza Vaccine Candidates in Mice and Ferrets
000730 (2014) Irina Isakova-Sivak [Russie] ; J Rgen De Jonge [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Andrey Rekstin [Russie] ; Geert Van Amerongen [Pays-Bas] ; Harry Van Dijken [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Paul Roholl [Pays-Bas] ; Victoria Kuznetsova [Russie] ; Elena Doroshenko [Russie] ; Vadim Tsvetnitsky [États-Unis] ; Larisa Rudenko [Russie]Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
000C34 (2011) Yanwei Zhong [République populaire de Chine] ; Jiong Cai [République populaire de Chine] ; Chuanfu Zhang [République populaire de Chine] ; Xiaoyan Xing [République populaire de Chine] ; Enqiang Qin [République populaire de Chine] ; Jing He [République populaire de Chine] ; Panyong Mao [République populaire de Chine] ; Jun Cheng [République populaire de Chine] ; Kun Liu [République populaire de Chine] ; Dongping Xu [République populaire de Chine] ; Hongbin Song [République populaire de Chine]Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A
001283 (2008) Tomy Joseph [États-Unis] ; Josephine Mcauliffe ; Bin Lu ; Leatrice Vogel ; David Swayne ; Hong Jin ; George Kemble ; Kanta SubbaraoA live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
001496 (2006) Kwang-Hee Lee [Corée du Sud] ; Sang-Uk Seo ; Jae-Min Song ; Chung-Min Lee ; Hyun-Ah Kim ; Baik L. SeongCharacterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
001B24 (1997) O. Andersen [Danemark] ; K. Vilsgaard Ravn ; I. Juul S Rensen ; G. Jonson ; E. Holm Nielsen ; S E SvehagSerum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro.
002128 (1990) I. N. Mbawuike ; H. R. Six ; T. R. Cate ; R. B. CouchVaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes
002D76 (????) F G Nagieva ; N I Krasnova ; V G Nikulina ; O G Andzhaparidze[The protective effect of hemagglutinin-specific monoclonal antibodies in experimental influenza infection].
002E11 (????) L A Stepanova ; A A Kovaleva ; M V Potapchuk ; A V Korotkov ; V V Kupriianov ; E A Blokhina ; R Iu Kotliarov ; L M Tsybalova[Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
000283 (2017) Mizuho Suzuki ; Masatoshi Okamatsu ; Takahiro Hiono ; Keita Matsuno ; Yoshihiro SakodaPotency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice
000531 (2015) Milton Thomas [États-Unis] ; Zhao Wang [États-Unis] ; Chithra C. Sreenivasan [États-Unis] ; Ben M. Hause [États-Unis] ; Gourapura J Renukaradhya [États-Unis] ; Feng Li [États-Unis] ; David H. Francis [États-Unis] ; Radhey S. Kaushik [États-Unis] ; Mahesh Khatri [États-Unis]Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
000577 (2015) Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Victor V. Kuprianov [Russie] ; Elena A. Blokhina [Russie] ; Marina V. Potapchuk [Russie] ; Alexander V. Korotkov [Russie] ; Andrey N. Gorshkov [Russie] ; Marina A. Kasyanenko [Russie] ; Nikolai V. Ravin [Russie] ; Oleg I. Kiselev [Russie]Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
000600 (2015) Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie]A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets.
000691 (2014) Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche]Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults
000D63 (2011) Danuta M. Skowronski [Canada] ; Travis S. Hottes [Canada] ; Janet E. Mcelhaney [Canada] ; Naveed Z. Janjua [Canada] ; Suzana Sabaiduc [Canada] ; Tracy Chan [Canada] ; Beth Gentleman [Canada] ; Dale Purych [Canada] ; Jennifer Gardy [Canada] ; David M. Patrick [Canada] ; Robert C. Brunham [Canada] ; Gaston De Serres [Canada] ; Martin Petric [Canada]Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age
000F05 (2010) Alicia Sol Rzano [États-Unis] ; Jianqiang Ye [États-Unis] ; Daniel R. Pérez [États-Unis]Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu▿
000F91 (2010) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Chin-Fen Yang [États-Unis] ; HONG JIN [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Evaluation of Replication and Cross-Reactive Antibody Responses of H2 Subtype Influenza Viruses in Mice and Ferrets
001087 (2009) Shufang Fan [République populaire de Chine] ; Yuwei Gao ; Kyoko Shinya ; Chris Kafai Li ; Yanbing Li ; Jianzhong Shi ; Yongping Jiang ; Yongbing Suo ; Tiegang Tong ; Gongxun Zhong ; Jiasheng Song ; Ying Zhang ; Guobin Tian ; Yuntao Guan ; Xiao-Ning Xu ; Zhigao Bu ; Yoshihiro Kawaoka [États-Unis] ; Hualan ChenImmunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.
001101 (2009) Jodi Mcgill [États-Unis] ; David K. Meyerholz ; Michelle Edsen-Moore ; Betty Young ; Ruth A. Coleman ; Annette J. Schlueter ; Thomas J. Waldschmidt ; Robert T. Cook ; Kevin L. LeggeFetal exposure to ethanol has long-term effects on the severity of influenza virus infections.
001132 (2009) Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta SubbaraoA live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
001225 (2008) Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton KatlinskySafety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
001273 (2008) David K. Meyerholz [États-Unis] ; Michelle Edsen-Moore ; Jodi Mcgill ; Ruth A. Coleman ; Robert T. Cook ; Kevin L. LeggeChronic alcohol consumption increases the severity of murine influenza virus infections.
001569 (2006) J. A. Desheva [Russie] ; X. H. Lu [États-Unis] ; A. R. Rekstin [Russie] ; L. G. Rudenko [Russie] ; D. E. Swayne [États-Unis] ; N. J. Cox [États-Unis] ; J. M. Katz [États-Unis] ; A. I. Klimov [États-Unis]Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential
001660 (2004) N. Hehme [Allemagne] ; H. Engelmann ; W. Kuenzel ; E. Neumeier ; R. SaengerImmunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
002641 (1982) B L Lu ; R G Webster ; V S HinshawFailure to detect hemagglutination-inhibiting antibodies with intact avian influenza virions.
002D79 (????) Iu A. Desheva ; Kh Lu ; A R Rekstin ; D M Kats ; L G Rudenko ; A I Klimov[The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
002D89 (????) N A Ivanova ; E B Grinbaum ; L Iu Taros ; T Ia Luzianina ; A A Smorodintsev[Serological foundation for the persisting circulation of influenza viruses A(HON1) and A(H2N2) among children].
000160 (2018) Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie]Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
000212 (2018) Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Marina A. Shuklina [Russie] ; Eugenia S. Mardanova [Russie] ; Roman Y. Kotlyarov [Russie] ; Marina V. Potapchuk [Russie] ; Sergei A. Petrov [Russie] ; Elena A. Blokhina [Russie] ; Nikolai V. Ravin [Russie]Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
000355 (2017) Troy C. Sutton [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Kevin W. Bock [États-Unis] ; Ian N. Moore [États-Unis] ; Wouter Koudstaal [Pays-Bas] ; Muniza Rehman [Pays-Bas] ; Gerrit Jan Weverling [Pays-Bas] ; Jaap Goudsmit [Pays-Bas] ; Kanta Subbarao [États-Unis]In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice
000449 (2016) J Rgen De Jonge [Pays-Bas] ; Irina Isakova-Sivak [Russie] ; Harry Van Dijken [Pays-Bas] ; Sanne Spijkers [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Rineke De Jong [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Paul Roholl [Pays-Bas] ; Larisa Rudenko [Russie]H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.
000465 (2016) Sergio M. Qui Ones-Parra [Australie] ; E. Bridie Clemens [Australie] ; Zhongfang Wang [Australie] ; Hayley A. Croom [Australie] ; Lukasz Kedzierski [Australie] ; Jodie Mcvernon [Australie] ; Dhanasekaran Vijaykrishna [Singapour] ; Katherine Kedzierska [Australie]A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses
000470 (2016) Naomi Komadina [Australie] ; Sergio M. Qui Ones-Parra [Australie] ; Katherine Kedzierska [Australie] ; James M. Mccaw [Australie] ; Anne Kelso [Australie] ; Karin Leder [Australie] ; Jodie Mcvernon [Australie]High conservation level of CD8+ T cell immunogenic regions within an unusual H1N2 human influenza variant
000499 (2015) Yu A. Desheva ; T A Smolonogina ; L G Rudenko[A preclinical trial of the reassortant influenza virus vaccine strain A/17/Quail/Hong Kong/97/84 (H9N2)].
000513 (2015) Daniel Dlugolenski [États-Unis] ; Les Jones [États-Unis] ; Elizabeth Howerth [États-Unis] ; David Wentworth [États-Unis] ; S. Mark Tompkins [États-Unis] ; Ralph A. Tripp [États-Unis]Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression
000522 (2015) Yulia A. Desheva [Russie] ; Tatiana A. Smolonogina [Russie] ; Svetlana A. Donina [Russie] ; Larisa G. Rudenko [Russie]Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
000556 (2015) Xiaolan Yang [République populaire de Chine] ; Jianyu Zhao [République populaire de Chine] ; Cheng Wang [République populaire de Chine] ; Yueqiang Duan [République populaire de Chine] ; Zhongpeng Zhao [République populaire de Chine] ; Rui Chen [République populaire de Chine] ; Liangyan Zhang [République populaire de Chine] ; Li Xing [République populaire de Chine] ; Chengcai Lai [République populaire de Chine] ; Shaogeng Zhang [République populaire de Chine] ; Xiliang Wang [République populaire de Chine] ; Penghui Yang [République populaire de Chine]Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge.
000566 (2015) Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Amanda Balish [États-Unis] ; Joyce Jones [États-Unis] ; Sharmi Thor [États-Unis] ; Charles Todd Davis [États-Unis] ; Melissa Pearce [États-Unis] ; Terrence Tumpey [États-Unis] ; David Cureton [États-Unis] ; Li-Mei Chen [États-Unis] ; Julie Villanueva [États-Unis] ; Tatiana L. Bousse [États-Unis]Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.
000589 (2015) Claudia Pappas ; Hua Yang ; Paul J. Carney ; Melissa B. Pearce ; Jacqueline M. Katz ; James Stevens ; Terrence M. TumpeyAssessment of transmission, pathogenesis and adaptation of H2 subtype influenza viruses in ferrets
000602 (2015) Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James R. Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie]A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets.
000697 (2014) Irina V. Alymova [États-Unis] ; Ian A. York [États-Unis] ; Jonathan A. Mccullers [États-Unis]Non-Avian Animal Reservoirs Present a Source of Influenza A PB1-F2 Proteins with Novel Virulence-Enhancing Markers
000741 (2014) Irina Isakova-Sivak [États-Unis, Russie] ; Li-Mei Chen [États-Unis] ; Melissa Bourgeois [États-Unis] ; Yumiko Matsuoka [États-Unis] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Alexander Klimov [États-Unis] ; Larisa Rudenko [Russie] ; Nancy J. Cox [États-Unis] ; Ruben O. Donis [États-Unis]Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model
000833 (2013) Alexandru Coman [Roumanie] ; Daniel N. Maftei ; Whitney S. Krueger ; Gary L. Heil ; John A. Friary ; Razvan M. Chereches ; Emanuela Sirlincan ; Paul Bria ; Claudiu Dragnea ; Iosif Kasler ; Gregory C. GraySerological evidence for avian H9N2 influenza virus infections among Romanian agriculture workers.
000864 (2013) Wen He [République populaire de Chine] ; Wei Wang ; Huamin Han ; Lei Wang ; Ge Zhang ; Bin GaoMolecular basis of live-attenuated influenza virus.
000A27 (2012) Filippo Ansaldi [Italie] ; Laura Valle ; Daniela De Florentiis ; Valentina Parodi ; Giuseppe Murdaca ; Bianca Bruzzone ; Paolo Durando ; Maurizio Setti ; Giancarlo IcardiPhase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults.
000C41 (2011) Huaxing Wu [République populaire de Chine] ; Beili Li [République populaire de Chine] ; Xue Wang [République populaire de Chine] ; Mingyuan Jin [République populaire de Chine] ; Guonian Wang [République populaire de Chine]Inhibitory Effect and Possible Mechanism of Action of Patchouli Alcohol against Influenza A (H2N2) Virus
000D60 (2011) Nobuko Ohshima [Japon] ; Yoshitaka Iba [Japon] ; Ritsuko Kubota-Koketsu [Japon] ; Yoshizo Asano [Japon] ; Yoshinobu Okuno [Japon] ; Yoshikazu Kurosawa [Japon]Naturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5
000E40 (2010) Ryan A. Langlois [États-Unis] ; Kevin L. LeggePlasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells.
000E67 (2010) Chih-Jen Wei [États-Unis] ; Jeffrey C. Boyington ; Patrick M. Mctamney ; Wing-Pui Kong ; Melissa B. Pearce ; Ling Xu ; Hanne Andersen ; Srinivas Rao ; Terrence M. Tumpey ; Zhi-Yong Yang ; Gary J. NabelInduction of broadly neutralizing H1N1 influenza antibodies by vaccination.
000E85 (2010) Pierre Van Damme [Belgique] ; Robert Arnou ; Froukje Kafeja ; Anne Fiquet ; Patrick Richard ; Stéphane Thomas ; Gilles Meghlaoui ; Sandrine Isabelle Samson ; Emilio LedesmaEvaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.
001044 (2009) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Safety, Immunogencity and Efficacy of a Cold-Adapted A/Ann Arbor/6/60 (H2N2) Vaccine in Mice and Ferrets
001121 (2009) Reiko Yoshida [Japon] ; Manabu Igarashi ; Hiroichi Ozaki ; Noriko Kishida ; Daisuke Tomabechi ; Hiroshi Kida ; Kimihito Ito ; Ayato TakadaCross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
001272 (2008) Jiezhong ChenComment on "Chronic alcohol consumption increases the severity of murine influenza virus infections".
001360 (2007) Heesik Yoon [États-Unis] ; Kevin L. Legge ; Sun-Sang J. Sung ; Thomas J. BracialeSequential activation of CD8+ T cells in the draining lymph nodes in response to pulmonary virus infection.
001383 (2007) Noelle K. Polakos [États-Unis] ; Ingo Klein ; Martin V. Richter ; Dietmar M. Zaiss ; Matthew Giannandrea ; Ian N. Crispe ; David J. TophamEarly intrahepatic accumulation of CD8+ T cells provides a source of effectors for nonhepatic immune responses.
001452 (2007) Alison Budd [Australie] ; Lisa Alleva [Australie] ; Mohammed Alsharifi [Australie] ; Aulikki Koskinen [Australie] ; Victoria Smythe [Australie] ; Arno Müllbacher [Australie] ; Jeff Wood [Australie] ; Ian Clark [Australie]Increased survival after gemfibrozil treatment of severe mouse influenza
001479 (2006) Annette Schrauder ; Brunhilde Schweiger ; Udo Buchholz ; Walter Haas ; Daniel Sagebiel ; Adrienne Guignard ; Wiebke HellenbrandLaboratory exposure to influenza A H2N2, Germany, 2004-2005.
001653 (2004) Thomas Palker [États-Unis] ; Irina Kiseleva ; Kimberly Johnston ; Qin Su ; Timothy Toner ; Christopher Szymkowiak ; Wan-Sang Kwan ; Boris Rubin ; Luba Petrukhin ; Joan Wlochowski ; Juanita Monteiro ; Nikolai Kraiouchkine ; Daniel Distefano ; Larisa Rudenko ; Alan Shaw ; Rima YouilProtective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
001739 (2003) G. A. Marsh [Australie] ; J. M. Watson [Australie] ; W. E. White [Australie] ; G. A. Tannock [Australie]An evaluation of the genetic stability and pathogenicity of the Russian cold-adapted influenza A donor strains A/Leningrad/134/17/57 and A/Leningrad/134/47/57 in ferrets
001A67 (1998) Suryaprakash Sambhara [Suède] ; Samantha Woods [Suède] ; Rita Arpino [Suède] ; Anjna Kurichh [Suède] ; Alan Tamane [Suède] ; Brian Underdown [Suède] ; Michel Klein [Suède] ; Karin Lövgren Bengtsson [Suède] ; Bror Morein [Suède] ; David Burt [Suède]Heterotypic Protection against Influenza by Immunostimulating Complexes Is Associated with the Induction of Cross-Reactive Cytotoxic T Lymphocytes
001A96 (1998) A. Natali [Italie] ; E. Pilotti [Italie] ; P. O. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni]Natural and ‘ In vitro ’ selected antigenic variants of influenza A virus (H2N2)
001E35 (1994) Innocent N. Mbawuike [États-Unis] ; Susan B. Dillon [États-Unis] ; Sandra G. Demuth [États-Unis] ; Christopher S. Jones [États-Unis] ; Thomas R. Cate [États-Unis] ; Robert B. Couch [États-Unis]Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein
001F31 (1992) S. Dea [Canada] ; R. Bilodeau ; R. Sauvageau ; C. Montpetit ; G P MartineauAntigenic variant of swine influenza virus causing proliferative and necrotizing pneumonia in pigs.
001F93 (1991) P W Gill ; A M Murphy ; A L CunninghamInfluenza A(H1N1): a widening spectrum?
002064 (1990) H. Závadová [République tchèque] ; E. Domorázková ; J. Skovránková ; M. Vodicková ; P. Ragac ; V. Vonka[Reactivity and immunologic activity of polyvalent split influenza vaccine in children].
002225 (1988) A. N. Slepushkin [Russie] ; P. A. Patriarca [États-Unis] ; N. P. Obrosova-Serova [Russie] ; M. W. Harmon [États-Unis] ; L. N. Kupryashina [Russie] ; S. G. Cheshik [Russie] ; R. B. Vartanyan [Russie] ; G. I. Alexandrova [Russie] ; F. I. Polezhaev [Russie] ; N. I. Lonskaya [Russie] ; B. V. Yagodovskii [Russie] ; A. P. Kendal [États-Unis] ; V. M. Zhdanov [Russie]Class-specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)-like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold-adapted donor strain
002231 (1988) M. H. Pritchard [Royaume-Uni] ; N. Matthews [Royaume-Uni] ; Julia Munro [Royaume-Uni]ANTIBODIES TO INFLUENZA A IN A CLUSTER OF CHILDREN WITH JUVENILE CHRONIC ARTHRITIS
002301 (1987) N. Masurel [Pays-Bas]Influenza A and B antibody status in Tanzania
002490 (1984) J. Wilczy Ski ; S. Kru ; R. Semkow ; M. Loza-TulimowskaMetaplasia of the lung respiratory epithelium and antibody dynamics in mice repeatedly infected with various subtypes of influenza virus A.
002498 (1984) N. Yamane [Japon] ; Y. Nakamura [Japon] ; M. Yuki [Japon] ; T. Odagiri [Japon] ; N. Ishida [Japon]Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers
002784 (1980) G Q Liu ; X C Gong ; J M Zhu ; G F Ren ; R L Fan ; W Q RuanAntigenic relationship between H1 and H2 of influenza A virus.
002883 (1979) F. Suzuki ; C. Suzuki ; E. Shimomura ; H. Maeda ; T. Fujii ; N. IshidaAntiviral and interferon-inducing activities of a new peptidomannan, KS-2, extracted from culture mycelia of Lentinus edodes.
002971 (1978) W. J. J. Anker ; A. K. Bakker ; N. MasurelCross-Protection in Mice After Immunization with H2N2, H3N2, and Heq2Neq2 Influenza Virus Strains
002B01 (1976) J M GwaltneyThe use of live attenuated influenza vaccine ts-1(E) in man.
002B03 (1976) V M Stealey ; D. Mccahon ; D S FreestonePreparation and characterization of live recombinant influenza vaccine.
002C03 (1974) G. C. Schild ; J. S. Oxford ; W. R. Dowdle ; M. Coleman ; M. S. Pereira ; P. ChakravertyAntigenic variation in current influenza A viruses: evidence for a high frequency of antigenic `drift' for the Hong Kong virus
002D84 (????) E P Grigor'Eva ; Iu A. Desheva ; S A Donina ; A N Na Khin ; A R Rekstin ; I B Barantseva ; E A Zavitkova ; T M Moskvicheva ; V G Zhavoronkov ; L G Rudenko[The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years].
002E02 (????) I M Isma Lova ; E I Isaeva ; Z I Rovnova[Monoreceptor antibodies to the hemagglutinin antigenic determinants of influenza viruses H2N2 and their virus-neutralizing activity].
002E10 (????) S G Markushin ; Iu Z. Gendon ; G G Krivtsov ; I I Akopova ; A S Sukhno ; A D Pereverzev[Increase of immunogenicity of cold-adapted influenza vaccine by using adjuvant].
002E14 (????) O N Ageeva ; Iu D. Sorokina ; R A Alibaeva ; N M Barmicheva ; N G Krauklis[Immune response of mice to experimental influenza].
002E26 (????) T A Smolonogina ; Iu A. Desheva ; A R Rekstin ; A N Mironov ; L G Rudenko[Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].
002E42 (????) I M Isma Lova ; E I Isaeva[Antigenic composition of the hemagglutinins of influenza viruses H2N2].
000286 (2017) Zhu-Nan Li [États-Unis] ; Jessica F. Trost [États-Unis] ; Kimberly M. Weber [États-Unis] ; Elizabeth H. Lemasters [États-Unis] ; Sharifa Nasreen [Bangladesh] ; Javan Esfandiari [États-Unis] ; Angelo H. Gunasekera [États-Unis] ; Megan Mccausland [États-Unis] ; Katharine Sturm-Ramirez [États-Unis] ; Jens Wrammert [États-Unis] ; Sean Gregory [États-Unis] ; Vic Veguilla [États-Unis] ; James Stevens [États-Unis] ; Joseph D. Miller [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Min Z. Levine [États-Unis]Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.
000406 (2016) Wei Wang ; Esmeralda Alvarado-Facundo ; Qiong Chen ; Christine M. Anderson [États-Unis] ; Dorothy Scott [États-Unis] ; Russell Vassell ; Carol D. WeissSerum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.
000420 (2016) Nachiket Shembekar [Inde] ; Vamsee V Aditya Mallajosyula [Inde] ; Ankita Malik [Inde] ; Ashok Saini [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde]Neutralization and Binding Profile of Monoclonal Antibodies Generated Against Influenza A H1N1 Viruses.
000439 (2016) Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Irina Kiseleva [Russie] ; Natalie Larionova [Russie] ; Larisa Rudenko [Russie] ; Xiyan Xu [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis]Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses.
000498 (2015) A V Lyapunov ; S I Kolesnikov ; M A Khasnatinov ; E L Manzarova ; I V Petrova ; V V Dolgikh ; G A Danchinova[Child and Adolescent Interepydemic Immunity to Influenza Viruses].
000565 (2015) Ankita Malik [Inde] ; V Vamsee Aditya Mallajosyula [Inde] ; Nripendra Nath Mishra [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde]Generation and Characterization of Monoclonal Antibodies Specific to Avian Influenza H5N1 Hemagglutinin Protein.
000653 (2014) Simon E. Hufton [Royaume-Uni] ; Paul Risley [Royaume-Uni] ; Christina R. Ball [Royaume-Uni] ; Diane Major [Royaume-Uni] ; Othmar G. Engelhardt [Royaume-Uni] ; Stephen Poole [Royaume-Uni]The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.
000739 (2014) Mai-Juan Ma [République populaire de Chine] ; Xiao-Xian Yang [République populaire de Chine] ; Yan-Hua Qian [République populaire de Chine] ; Si-Yan Zhao [République populaire de Chine] ; Sha Hua [République populaire de Chine] ; Tie-Cheng Wang [République populaire de Chine] ; Shan-Hui Chen [République populaire de Chine] ; Guang-Yuan Ma [République populaire de Chine] ; Xiao-Yu Sang [République populaire de Chine] ; Lin-Na Liu [République populaire de Chine] ; Ai-Ping Wu [République populaire de Chine] ; Tai-Jiao Jiang [République populaire de Chine] ; Yu-Wei Gao [République populaire de Chine] ; Gregory C. Gray [États-Unis] ; Teng Zhao [République populaire de Chine] ; Xia Ling [République populaire de Chine] ; Jing-Lin Wang [République populaire de Chine] ; Bing Lu [République populaire de Chine] ; Jun Qian [République populaire de Chine] ; Wu-Chun Cao [République populaire de Chine]Characterization of a Novel Reassortant Influenza A Virus (H2N2) from a Domestic Duck in Eastern China
000825 (2013) Cyrille Dreyfus ; Damian C. Ekiert ; Ian A. WilsonStructure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin
000A21 (2012) Juergen A. Richt [États-Unis] ; Barry Rockx [Canada] ; Wenjun Ma [États-Unis] ; Friederike Feldmann [Canada] ; David Safronetz [Canada] ; Andrea Marzi [Canada] ; Darwyn Kobasa [Canada] ; James E. Strong [Canada] ; Lisa Kercher [États-Unis] ; Dan Long [États-Unis] ; Don Gardner [États-Unis] ; Douglas Brining [États-Unis] ; Heinz Feldmann [Canada]Recently Emerged Swine Influenza A Virus (H2N3) Causes Severe Pneumonia in Cynomolgus Macaques
000A62 (2012) Masanori Terajima ; Jenny Aurielle B. Babon ; Francis A. EnnisEpidemiology of the Influenza A Virus H5N1 Subtype and Memory of Immunity to the H2N2 Subtype
000A72 (2012) Gunisha Pasricha ; Akhilesh C. Mishra ; Alok K. ChakrabartiComprehensive global amino acid sequence analysis of PB1F2 protein of influenza A H5N1 viruses and the influenza A virus subtypes responsible for the 20th‐century pandemics
000A85 (2012) Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta SubbaraoAn open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
000B46 (2012) Jens C. Krause [États-Unis] ; Tshidi Tsibane [États-Unis] ; Terrence M. Tumpey [États-Unis] ; Chelsey J. Huffman [États-Unis] ; Randy Albrecht [États-Unis] ; David L. Blum [États-Unis] ; Irene Ramos [États-Unis] ; Ana Fernandez-Sesma [États-Unis] ; Kathryn M. Edwards [États-Unis] ; Adolfo Garcia-Sastre [États-Unis] ; Christopher F. Basler [États-Unis] ; James E. Jr Crowe [États-Unis]Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
000C28 (2011) Darisuren Anhlan [Allemagne] ; Norbert Grundmann ; Wojciech Makalowski ; Stephan Ludwig ; Christoph ScholtissekOrigin of the 1918 pandemic H1N1 influenza A virus as studied by codon usage patterns and phylogenetic analysis.
000C81 (2011) Kortney M. Gustin [États-Unis] ; Taronna R. Maines ; Jessica A. Belser ; Neal Van Hoeven ; Xuihua Lu ; Libo Dong ; Irina Isakova-Sivak ; Li-Mei Chen ; J Theo M. Voeten ; Jacco G M. Heldens ; Han Van Den Bosch ; Nancy J. Cox ; Terrence M. Tumpey ; Alexander I. Klimov ; Larisa Rudenko ; Ruben O. Donis ; Jacqueline M. KatzComparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets.
000C86 (2011) Chao Qiu ; Yang Huang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Di Tian ; Wanju Zhang ; Yunwen Hu ; Zhenghong Yuan ; Xiaoyan Zhang ; Jianqing XuBoosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021